Neogen (NEOG) Capital Expenditures Growth (1y) (2011 - 2026)
Neogen (NEOG) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | -47.73% |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn | -64.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -64.66% |
| Nov 30, 2025 | -31.99% |
| Aug 31, 2025 | -37.55% |
| May 31, 2025 | -33.64% |
| Feb 28, 2025 | 2.46% |
| Nov 30, 2024 | -29.73% |
| Aug 31, 2024 | 25.48% |
| May 31, 2024 | -4.90% |
| Feb 29, 2024 | 112.01% |
| Nov 30, 2023 | 101.69% |
| Aug 31, 2023 | 135.69% |
| May 31, 2023 | 103.41% |
| Feb 28, 2023 | 127.63% |
| Nov 30, 2022 | 207.26% |
| Aug 31, 2022 | 903.55% |
| May 31, 2022 | 71.31% |
| Feb 28, 2022 | -19.82% |
| Nov 30, 2021 | -42.43% |
| Aug 31, 2021 | -69.52% |
| May 31, 2021 | -5.32% |